SWKH News and Press, SWK Holdings Corporation From 06/02/20

BOONTON, N.J. , June 2, 2020 /PRNewswire/ -- Enteris BioPharma, Inc. , a biotechnology company developing innovative drug products built around its proprietary delivery technologies and a wholly-owned subsidiary of SWK Holdings Corporation (Nasdaq: SWKH), announced that the company is pa...

DALLAS , May 14, 2020 /PRNewswire/ -- Corporate Highlights Core specialty finance segment generated an 11.3% adjusted ROIC, and yielding assets increased to $179.2 million , a 15.7% increase in comparison to the quarter ended March 31, 2019 Rajiv Khosla , Ph.D. appointed as C...

BOONTON, N.J. , May 4, 2020 /PRNewswire/ --  Enteris BioPharma, Inc. , a biotechnology company developing innovative drug products built around its proprietary delivery technologies and a wholly-owned subsidiary of SWK Holdings Corporation (Nasdaq: SWKH), today announced the hiring o...

SWK Holdings Corporation (SWKH) Q4 2019 Earnings Conference Call March 31, 2020 10:00 AM ET Company Participants Jason Rando - Tiberend Strategic Advisors, Inc. Winston Black - Chairman and Chief Executive Officer Conference Call Participants Presentation Operator Goo...

DALLAS , March 30, 2020 /PRNewswire/ -- Corporate Highlights Core specialty finance segment generated a 12.6% adjusted ROIC and yielding assets increased 4.8% year over year to $175.1 million Closed Enteris Biopharma acquisition SWK Holdings common stock uplisted to Nasdaq C...

DALLAS , March 26, 2020 /PRNewswire/ -- SWK Holdings Corporation (Nasdaq: SWKH), a life sciences focused specialty finance company catering to small and mid-sized commercial-stage companies, today announced its preliminary revenue and non-GAAP adjusted net income for the fourth quart...

DALLAS , Feb. 28, 2020 /PRNewswire/ -- SWK Holdings Corporation (Nasdaq: SWKH), a life sciences focused specialty finance company catering to small- and mid-sized commercial-stage companies, today provided an update on the progress and achievements of its partner companies during the...

BOONTON, N.J. , Feb. 10, 2020 /PRNewswire/ --  Enteris BioPharma, Inc. , a biotechnology company developing innovative drug products built around its proprietary delivery technologies and a wholly-owned subsidiary of SWK Holdings Corporation (Nasdaq: SWKH), today announced the hiring...

BOONTON, N.J. , Jan. 27, 2020 /PRNewswire/ --  Enteris BioPharma, Inc. , a biotechnology company developing innovative drug products built around its proprietary delivery technologies and a wholly-owned subsidiary of SWK Holdings Corporation (Nasdaq: SWKH), announced that it has rece...

DALLAS , Jan. 23, 2020 /PRNewswire/ -- SWK Holdings Corporation (Nasdaq: SWKH), a life science focused specialty finance company, today announced that its shares of common stock will begin trading on the Nasdaq Capital Market beginning today at 9:30 a.m., EST under the ticker symbo...